On the recordMarch 30, 2023
In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Source
congress.govEditor's note · Context
Discusses findings from an investigation into insulin pricing.
Share & report
More from Chuck Grassley
Feb 11, 2025
Congress was not provided the legally required 30-day notice and case-specific reasons for removal, as required by law.
Jun 17, 2025
Grassley sent a letter Tuesday asking Patel for additional information about how the intelligence information report was handled.
May 5, 2025
I want to put people on the agenda that I can help the president be successful in his nominees, and that’s all I can say at this point.
Other voices in this conversation
